Common cutaneous signs unmasking a severe hematological disorder: GATA2 deficiency

Authors

  • Firdaouss Boukamza Department of Dermatology and Venereology, Mohammed VI University Hospital, Tangier, Morocco , Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, Tangier, Morocco Author
  • Ouiame El Jouari Department of Dermatology and Venereology, Mohammed VI University Hospital, Tangier, Morocco , Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, Tangier, Morocco Author
  • Farah Hacht Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, Tangier, Morocco , Department of Medical Genetics and Oncogenetics, Mohammed VI University Hospital, Tangier, Morocco Author
  • Afaf Lamzouri Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, Tangier, Morocco , Department of Medical Genetics and Oncogenetics, Mohammed VI University Hospital, Tangier, Morocco Author
  • Salim Gallouj Department of Dermatology and Venereology, Mohammed VI University Hospital, Tangier, Morocco , Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, Tangier, Morocco Author

DOI:

https://doi.org/10.25251/bja9kb72

Keywords:

acute myeloid leukemia, GATA2 deficiency, immunodeficiency

Abstract

GATA2 deficiency is a rare genetic disorder with heterogeneous clinical manifestations affecting the immune, hematologic, and vascular systems. We report the case of a 31-year-old woman with primary lymphedema progressing since childhood, associated with diffuse treatment-resistant warts and severe monocytopenia. Genetic testing revealed a mutation in the GATA2 gene (c.1078T>C), resulting in complete loss of protein function. The patient also exhibited leukopenia and anemia, and bone marrow evaluation confirmed progression to acute myeloid leukemia. The immune deficiencies caused by this mutation explain the increased susceptibility to recurrent infections, particularly persistent human papillomavirus infections responsible for the extensive warts in this patient. The frequent progression to myelodysplastic syndromes and leukemia underscores the severity of this condition and the importance of early diagnosis. Management requires close monitoring, with hematopoietic stem cell transplantation representing the only curative option to improve prognosis and prevent progression to life-threatening complications. This case highlights the need for prompt identification of GATA2 mutations in patients with suggestive clinical features to optimize surveillance and treatment.

References

1. Hsu AP, Sampaio EP, Khan J,et al . Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118:2653-5. [PMID: 21670465].

2. Spinner MA, Sanchez LA, Hsu AP ,et al . GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809-21. [PMID: 24227816].

3. Santiago M, Liquori A, Such E, Zúñiga Á, Cervera J. The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency. Cancers (Basel). 2023;15:1590. [PMID: 36900380].

4. Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15:968-80. [PMID: 26049967].

5. Calvo KR, Hickstein DD. The spectrum of GATA2 deficiency syndrome. Blood. 2023;141:1524-1532. [PMID: 36455197].

6. Donadieu J, Lamant M, Fieschi C, et al . Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica. 2018;103:1278-1287. [PMID: 29724903].

7. Hsu AP, McReynolds LJ, Holland SM. GATA2 deficiency. Curr Opin Allergy Clin Immunol. 2015;15:104-9. [PMID: 25397911].

8. Wlodarski MW, Collin M, Horwitz MS. GATA2 deficiency and related myeloid neoplasms. Semin Hematol. 2017;54:81-86. [PMID: 28637621].

9. Belohlavkova P, Hrochova K, Fatorova I, Zak P. MonoMAC syndrome with GATA2 novel mutation: A case report. Leuk Res Rep. 2022;18:100346. [PMID: 36119727].

10. Nichols-Vinueza DX, Parta M, Shah NN, et al . Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency. Br J Haematol. 2022;196:169-178. [PMID: 34580862] .

11. Dickinson RE, Milne P, Jardine L,et al. The evolution of cellular deficiency in GATA2 mutation. Blood. 2014;123:863-74. [PMID: 24345756].

12. Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208:227-34. [PMID: 21242295].

Downloads

Published

01/05/2026